arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

BLUE BIOFUELS, INC.

BIOF

— Price unavailable

12 Visible periods

23 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

BLUE BIOFUELS, INC. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC 79.2% ↘

FCF / Share $-0.00 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close.

12-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-2.87M

↓ -102.6% —

FCF / Share Free cash flow per share

$-0.00

↑ +17.2% —

Long-Term Debt Long-term obligations

$1.25M

— 0.0% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↓

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
EPS Growth YoY (%)	-80.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	50.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	28.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-75.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-102.6% Weak ↓ Weak Declining Year-over-year change in net income	53.6% Excellent ↑ Excellent Improving Year-over-year change in net income	22.9% Good ↑ Good Improving Year-over-year change in net income	-85.1% Weak ↓ Weak Declining Year-over-year change in net income	1.9% Caution ↑ Caution Improving Year-over-year change in net income	78.7% Excellent ↑ Excellent Improving Year-over-year change in net income	-23.4% Weak ↑ Weak Improving Year-over-year change in net income	-61.2% Weak ↑ Weak Improving Year-over-year change in net income	47.4% Excellent Excellent Year-over-year change in net income	-325.2% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	17.2% Good ↓ Good Declining Year-over-year change in free cash flow	43.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	19.3% Good ↑ Good Improving Year-over-year change in free cash flow	21.6% Good Good Year-over-year change in free cash flow	-113.9% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
FCF / Net Income (x)	0.32x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.76x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.62x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.25x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.27x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.43x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.31x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.23x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	79.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	112.6% Excellent → Excellent Stable Return earned on debt + equity capital invested Optimal: > 10%	70.8% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	131.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	122.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	47.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-497.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-63.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-111.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-26.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-264.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-291.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-309.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-355.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-118.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-223.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-107.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-47.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-92.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-21.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	77.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+546%)	49.9% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+316%)	85.8% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+615%)	168.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1300%)	153.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1177%)	65.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+445%)	—	-155.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1397%)	-124.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1137%)	-233.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-2046%)	-35.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	0.30x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-40%)	0.30x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-40%)	—	—
Interest Coverage (x)	—	—	—	—	—	—	-75.19x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.40x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-89.55x Weak Weak Operating income divided by interest expense Optimal: > 5x	-688.85x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-65.20K	$-48.80K	$-41.01K	$-211.90K	$-1.16M	$-286.58K	$-55.08K	$-49.68K	$1.19M	$1.04M	$-48.97K	$-4.00
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	-0.23x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.16x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—

📊 What does each share earn? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
Basic EPS, GAAP (USD)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.00	$-0.00	$-0.01	$-0.01	$-0.01	$-0.00	—	—	—	—	—	—
Book Value per Share (USD)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$0.01	$0.07	$0.10	$0.10	$0.20	$-0.00
Tangible Book Value per Share (USD)	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$-0.01	$0.01	$0.07	$0.10	$0.10	$0.20	$-0.00
Basic Weighted Avg Shares (shares)	312.19M	303.85M	299.95M	278.83M	269.64M	229.88M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
Working Capital (USD)	$-2.91M	$-2.13M	$-1.43M	$-383.70K	$713.55K	$-766.55K	—	$-2.95M	$-3.02M	$-2.34M	$-1.90M	—
LT Debt (USD)	—	—	—	—	—	—	—	—	$1.25M	$1.25M	—	—
Total Equity (USD)	$-3.71M	$-2.85M	$-3.56M	$-2.36M	$-1.40M	$-3.34M	$780.26K	$5.34M	$4.14M	$4.20M	$6.54M	$-55.16K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2017 10-K ↗	FY 2018 Dec 31, 2016 10-K ↗	FY 2017 Dec 31, 2015 10-K ↗	FY 2016 Dec 31, 2014 10-K ↗	FY 2015 Dec 31, 2013 10-K ↗	FY 2014 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	$134.32K	—	—	—	—	—
Depreciation Expense (USD)	$120.69K	$118.80K	$119.48K	$55.60K	$52.69K	$40.12K	—	—	—	—	—	—
Net Income, GAAP (USD)	$-2.87M	$-1.42M	$-3.06M	$-3.96M	$-2.14M	$-2.18M	$-10.26M	$-8.32M	$-5.16M	$-9.80M	$-2.30M	—
Operating Cash Flow (USD)	$-845.00K	$-1.00M	$-1.60M	$-2.04M	$-2.47M	$-921.45K	$-1.84M	$-2.24M	$-2.01M	$-2.88M	$-517.56K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 12 years · 49 quarters

BLUE BIOFUELS, INC.

Analytical Summary

12-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare BIOF with peers